Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
Healthy Volunteers
NCT06289478

Efficacy and Safety of Retrograde Intraarticular Injection, Topical Soaking of Tranexamic Acid (TXA), or Placebo in Femoral Neck Fractured Patients Undergoing Cementless Bipolar Hemiarthroplasty

Led by King Chulalongkorn Memorial Hospital · Updated on 2024-10-30

75

Participants Needed

2

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this Randomized controlled trial is to evaluate in household ambulatory, elderly patients sustaining femoral neck fracture who are subjected to be treat with cementless bipolar hemiarthroplasty. The main questions it aims to answer are: * The efficacy in reducing blood transfusion for topical tranexamic acid administration * The safety of tranexemic acid, topically used As having undergone bipolar hemiarthroplasty surgery, participants will either receive retrograde intraarticular tranexamic acid injection via drain tube, or topical soaking administration. Researchers will compare, with standard procedure (procedure), whether topically administered tranexamic acid would reduce rate of blood transfusion.

CONDITIONS

Official Title

Efficacy and Safety of Retrograde Intraarticular Injection, Topical Soaking of Tranexamic Acid (TXA), or Placebo in Femoral Neck Fractured Patients Undergoing Cementless Bipolar Hemiarthroplasty

Who Can Participate

Age: 60Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Elderly patients aged over 60 years
  • Femoral neck fracture caused by low energy mechanism
  • Ability to walk around the household
  • Scheduled for cementless bipolar hemiarthroplasty at KCMH
  • Able to provide informed consent
Not Eligible

You will not qualify if you...

  • Allergy to tranexamic acid (TXA)
  • History of venous thromboembolism (VTE)
  • Previous hip surgery, hip infection, or pathological fracture
  • Congenital or acquired blood clotting disorders
  • Hemoglobin less than 10 g/dL or platelet count less than 140,000

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Faculty of Medicine, King Chulalongkorn Memorial Hospital

Bangkok, Thailand, 10330

Actively Recruiting

2

Faculty of Medicine

Bangkok, Thailand, 10330

Not Yet Recruiting

Loading map...

Research Team

K

Kanyakorn Riewruja, Medical degree

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here